Literature DB >> 31676056

Pediatric Inflammatory Bowel Disease: Special Considerations.

Megan K Fuller1.   

Abstract

Pediatric inflammatory bowel disease may present differently than adult onset disease. It is important to consider a broader differential diagnosis in very early onset disease. Diagnostic and treatment decisions must consider the long term risks and benefits over a lifetime. Surgical triggers in children may include impaired growth and inability to wean from steroids in addition to standard adult indications. Effective transition of care to adult providers is a key to prevent flares and loss of follow-up.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pediatric Crohn’s disease; Pediatric IBD–unclassified; Pediatric inflammatory bowel disease; Pediatric ulcerative colitis; Very early onset IBD (VEOIBD)

Mesh：

Year:  2019        PMID： 31676056     DOI： 10.1016/j.suc.2019.08.008

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  4 in total

1.  Arbutin ameliorated ulcerative colitis of mice induced by dextran sodium sulfate (DSS).

Authors:  Chuan Zhang; Huiping Zhu; Hui Jie; Hengyue Ding; Hongwen Sun
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

2.  Atractylenolide III inhibits epithelial‑mesenchymal transition in small intestine epithelial cells by activating the AMPK signaling pathway.

Authors:  Mingjin Huang; Wenwen Jiang; Chunli Luo; Min Yang; Yan Ren
Journal:  Mol Med Rep       Date:  2022-01-28       Impact factor: 3.423

3.  Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.

Authors:  Wenhui Zhang; Astrid Scalori; Franklin Fuh; Jacqueline McBride; Gaohong She; Jaroslaw Kierkus; Bartosz Korczowksi; Regan Li; Mariam Abouhossein; Alysha Kadva; K T Park; Meina Tao Tang
Journal:  Inflamm Bowel Dis       Date:  2022-09-01       Impact factor: 7.290

4.  JNK pathway-associated phosphatase illustrates low expression and negative correlations with inflammation, disease activity, and T-helper 17 cells in inflammatory bowel disease children.

Authors:  Caixia Wang; Cui Bai; Chenggang Mao; Xuefei Leng; Fang Wang; Xingqing Guo
Journal:  J Clin Lab Anal       Date:  2022-07-31       Impact factor: 3.124
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.